Previous 10 | Next 10 |
10x Genomics Surpasses 100 Xenium Analyzer Shipments PR Newswire Rapid growth and adoption of Xenium Analyzer demonstrates strength of company's innovation engine, broad commercial reach and operational scale PLEASANTON, Calif. , Aug. 29, 2023 /PRNewswire...
2023-08-14 08:15:00 ET Summary This article provides a dashboard with industry metrics in healthcare, then focus on the Global X Genomics & Biotechnology ETF. Pharmaceuticals/biotechnology and healthcare providers have fair value and quality scores. Healthcare equipment is...
2023-08-03 22:28:06 ET 10X Genomics, Inc. (TXG) Q2 2023 Earnings Conference Call August 03, 2023, 16:30 ET Company Participants Cassie Corneau - Manager, IR and Strategic Finance Serge Saxonov - Co-Founder, CEO & Director Justin McAnear - CFO Conference...
2023-08-03 16:37:36 ET 10x Genomics press release ( NASDAQ: TXG ): Q2 GAAP EPS of -$0.53. Revenue of $146.8M (+28.1% Y/Y). Cash and cash equivalents and marketable securities were $391.4 million as of June 30, 2023. 10x Genomics is raising its full year 2023 r...
10x Genomics Reports Second Quarter 2023 Financial Results PR Newswire PLEASANTON, Calif. , Aug. 3, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the second quarter ended J...
On track to meet full year production and cost guidance (All amounts expressed in U.S. Dollars unless otherwise stated) TORONTO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Torex Gold Resources Inc. (the “Company” or “Torex”) (TSX: TXG) reports the Company’s financi...
(All amounts expressed in US. Dollars unless otherwise stated) TORONTO, July 26, 2023 (GLOBE NEWSWIRE) -- Torex Gold Resources Inc. (the “Company” or “Torex”) (TSX: TXG) provides the third quarterly update on the development of its Media Luna Project (“Media...
Shares of 10x Genomics, Inc. (NASDAQ: TXG) traded at a new 52-week high today and are currently trading at $59.24. So far today, approximately 246.45k shares have been exchanged, as compared to an average 30-day volume of 913.07k shares. 10x Genomics, Inc., a life science technology company, ...
2023-07-15 04:25:01 ET Summary The memo reads that the bear market has been cancelled, and there are few who are as happy about the change in fortunes as Cathie Wood and ARK Funds. Her flagship ARKK fund, as well as other ARK family funds, have had an impressive run lately and wer...
10x Genomics to Report Second Quarter 2023 Financial Results on August 3, 2023 PR Newswire PLEASANTON, Calif. , July 13, 2023 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it will report financial re...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 06:00:09 ET Kyle Mikson from Canaccord Genuity issued a price target of $32.00 for TXG on 2024-07-23 05:09:00. The adjusted price target was set to $32.00. At the time of the announcement, TXG was trading at $18.11. The overall price target consensus is at $24...
10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PLEASANTON, Calif. , July 12, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it will report fi...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 248.0% to $0.6682 on volume of 430,252,408 shares Maxeon Solar Technologies Ltd. (MAXN) fell 15.0% to $0.2108 on volume of 237,403,092 shares NVIDIA Corporation (NVDA) rose 2.7% to $134.91 on vol...